US Patent Issued to University College Cardiff Consultants, University of Birmingham on Sept. 1 for "Phosphoantigen prodrug compounds" (British Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,055, issued on Sept. 1, was assigned to University College Cardiff Consultants Ltd (Cardiff, Great Britain) and University of Birmingham (Birmingham, Great Britain).

"Phosphoantigen prodrug compounds" was invented by Youcef Mehellou (Cardiff, Great Britain) and Benjamin Willcox (Birmingham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a compound of General Formula (I): wherein R1, R2, R3, R4 and R5 are as defined herein. Compounds and compositions comprising the same exhibit high serum stability and potent activation of the GammaDelta T-cell immune response, so are suitable for use in immunotherapy. The inven...